558sek
0,7 %
Date:2024-04-25Time:17:29:00Latest report:Q4-2023List:Small CapTicker:NICA
Market Cap:247 msekEnterprise Value:237 msekNet Sales:1,44 msekEarnings:-75,2 msekEmployees:0ISIN:SE0005454873

Ratios

10-year key figure history for Nanologica turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanologica with index and moving average MA50 and MA200.

Stockprice:5,58
MA50:6,53
MA200:9,21
Price/MA200:-39,4 %
RSI (14):39,7
Price/MA50:-14,5 %

Description

Nanologica AB develops and manufactures nanoporous silica particles for life science applications. It focuses on two areas: Drug Development and Chromatography. The company's drug delivery platforms are NLAB Spiro and NLAB Silica, which focus on producing medicines for the benefit of patients. Its geographical segments are Sweden, China, India, the United States, and the Rest of the world.

Biotechnology